Krystal Biotech (KRYS) PT Raised to $140 at Chardan Capital Markets, Following Clinical Business Update
Chardan Capital Markets analyst Geulah ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
